We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.03B
AUM Growth
–
Cap. Flow
+$8.05B
Cap. Flow
% of AUM
100.3%
Top 10 Holdings %
Top 10 Hldgs %
18.06%
Holding
2,281
New
2,279
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$264M |
| 2 |
Johnson & Johnson
JNJ
|
+$229M |
| 3 |
Chevron
CVX
|
+$157M |
| 4 |
Procter & Gamble
PG
|
+$143M |
| 5 |
IBM
IBM
|
+$130M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.36% |
| 2 | Healthcare | 12.61% |
| 3 | Industrials | 12.03% |
| 4 | Financials | 10.68% |
| 5 | Energy | 10.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Smith & Wesson
SWBI
$665M
| $155K | ﹤0.01% |
+20,419
| New | +$142K |
|
|
CAJ
1102
DELISTED
Canon, Inc.
CAJ
| $155K | ﹤0.01% |
+4,717
| New | +$167K |
|
1103
Acuity Brands
AYI
$9.98B
| $154K | ﹤0.01% |
+2,050
| New | +$152K |
|
1104
iShares S&P 500 Value ETF
IVE
$49.1B
| $153K | ﹤0.01% |
+2,028
| New | +$154K |
|
1105
Williams-Sonoma
WSM
$27.1B
| $153K | ﹤0.01% |
+5,480
| New | +$148K |
|
|
PGNX
1106
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $153K | ﹤0.01% |
+34,468
| New | +$155K |
|
1107
BJ's Restaurants
BJRI
$1.42B
| $152K | ﹤0.01% |
+4,110
| New | +$146K |
|
1108
Broadridge
BR
$17.6B
| $152K | ﹤0.01% |
+5,782
| New | +$149K |
|
1109
Cabot Corp
CBT
$4.62B
| $152K | ﹤0.01% |
+4,070
| New | +$151K |
|
1110
State Street Materials Select Sector SPDR ETF
XLB
$8.65B
| $152K | ﹤0.01% |
+7,980
| New | +$158K |
|
|
RAVN
1111
DELISTED
Raven Industries Inc
RAVN
| $152K | ﹤0.01% |
+5,093
| New | +$162K |
|
1112
Atmos Energy
ATO
$29.9B
| $151K | ﹤0.01% |
+3,700
| New | +$158K |
|
1113
Sun Life Financial
SLF
$45.8B
| $151K | ﹤0.01% |
+5,123
| New | +$146K |
|
1114
VanEck Indonesia Index ETF
IDX
$31.5M
| $150K | ﹤0.01% |
+5,200
| New | +$162K |
|
1115
Aaon
AAON
$8.24B
| $149K | ﹤0.01% |
+15,289
| New | +$137K |
|
1116
AptarGroup
ATR
$8.51B
| $149K | ﹤0.01% |
+2,701
| New | +$152K |
|
|
DELL
1117
DELISTED
DELL INC
DELL
| $149K | ﹤0.01% |
+11,290
| New | +$153K |
|
|
VIVO
1118
DELISTED
Meridian Bioscience Inc
VIVO
| $148K | ﹤0.01% |
+6,915
| New | +$149K |
|
1119
Estee Lauder
EL
$29.4B
| $147K | ﹤0.01% |
+2,241
| New | +$153K |
|
1120
Prudential
PUK
$36.9B
| $147K | ﹤0.01% |
+4,649
| New | +$153K |
|
1121
CBRE Group
CBRE
$41.8B
| $146K | ﹤0.01% |
+6,295
| New | +$150K |
|
1122
iShares MSCI Australia ETF
EWA
$1.37B
| $146K | ﹤0.01% |
+6,500
| New | +$168K |
|
1123
Forward Air
FWRD
$492M
| $146K | ﹤0.01% |
+3,839
| New | +$146K |
|
1124
Harley-Davidson
HOG
$2.66B
| $146K | ﹤0.01% |
+2,681
| New | +$145K |
|
|
ALXN
1125
DELISTED
Alexion Pharmaceuticals
ALXN
| $146K | ﹤0.01% |
+1,595
| New | +$154K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Glenmede Trust, which disclosed 2,281 positions worth $8.03B. Its ten largest holdings account for 18% of the portfolio.
Its largest position is ExxonMobil: 2,929,510 shares worth $265M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, followed by Healthcare and Industrials.
- Glenmede Trust's largest Q2 2013 buy was ExxonMobil: 2,929,510 shares worth $265M.
- Glenmede Trust's ten largest holdings make up 18% of its $8.03B portfolio in Q2 2013.
- Glenmede Trust disclosed 2,281 positions in Q2 2013, its first 13F filing on record.
Based on Glenmede Trust's 13F filing for Q2 2013, filed 15 Aug 2013.